We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
05 Mar 2022 - 09 Mar 2022
Virtual Venue

Global Coagulometers Market to Be Driven by Rising Prevalence of Blood Disorders

By LabMedica International staff writers
Posted on 13 Jan 2022
Print article
Illustration
Illustration

The global coagulometers market is being driven by a rise in the incidence and prevalence of blood disorders such as hemophilia that is fueling the demand for more diagnostic tools.

These are the latest findings of Transparency Market Research (Albany NY, USA), a market intelligence provider.

Coagulation is a process wherein certain proteins and blood cells together create a gel-like clot to stop bleeding from a damaged or leaking blood vessel. Coagulometer is a device that is used to evaluate the efficiency of blood factors to form a clot. Coagulometers are widely used across the globe to diagnose hemophilia and other genetic hematological diseases. They are also used to monitor the progression of treatment with anti-coagulants in affected patients. These devices detect the time taken for coagulation in an ambient environment. Before the introduction of semi-automated and automated coagulation analyzers, these tests were performed manually. They involved high cost, skilled labor, and high probability of errors.

There has been rise in the incidence and prevalence of blood disorders such as hemophilia over the last few years. This high prevalence of blood disorders is estimated to drive the demand for more diagnostic tools, which in turn, is likely to propel the growth of the global coagulometers market. Moreover, the rising consumption of anti-coagulant drugs such as aspirin and heparin that necessitates the use of coagulometers to monitor the treatment progress in those patients is also fueling market growth. However, the high cost of these devices is diverting potential users towards manual coagulation testing, which is expected to restrain the growth of the global coagulometers market.

Based on technology, the global coagulometers market is dominated by the photo-optical detection and electrochemical detection segments which hold the highest market share as most automated coagulometers work on the principle of photo-optical or electrochemical detection. Based on channel type, the multichannel coagulometers segment holds the largest share in the global coagulometers market as multichannel coagulometers are widely used in diagnostic laboratories and hospitals. Based on end-user, the hospitals & diagnostic laboratories segment is expected to account for a major share of the global coagulometers market.

Geographically, North America is expected to hold a major share of the global coagulometers market, owing to high adoption of technology and high expenditure on health care by public and private sectors in the region. Europe is anticipated to account for a significant share of the global coagulometers market due to the high prevalence of blood disorders in the region. Local governing bodies in Asia Pacific are investing in the development of health care facilities and academic research institutes in the region, which is projected to propel the market for coagulometers in the region.

Related Links:
Transparency Market Research 

Gold Supplier
SARS-CoV-2 qRT-PCR IVD Reagent Kit
SARS-CoV-2 qRT-PCR Dx Kit (CE-IVD)
New
Electrolyte Analyzer
CARELYTE-500 Series
New
POC RT-PCR COVID-19 Testing Platform
Convergys POC RT-PCR COVID-19 Testing Platform
New
Integrated Urinalysis Chemistry Analyzer
AVE-772

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: The ultrarapid genome sequencing pipeline, indicating all processes from sample collection to a diagnosis. Vertically stacked processes are run in parallel (Photo courtesy of Stanford University)

Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting

A genetic diagnosis can guide clinical management and improve prognosis in critically ill patients, and much effort has gone into developing methods that result in rapid, reliable results.... Read more

Hematology

view channel
Image: My Qualiris QC (Photo courtesy of Stago)

Stago Launches New My Qualiris QC Website for Brand-New User Experience

Stago (Paris, France) has launched its new My Qualiris QC website which provides a brand-new user experience with a 24/7 accessible web-application where the results of a user’s network are only a few clicks away.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.